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Steroid treatment should be started without delay to 
avoid the high risk of blindness.
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Arthritis and Spondylodiscitis Caused by M ycobac­
terium xenopi in a Patient with Systemic
Erythematosus
S ir— We read with interest the article by 
et al. [1], on a case o f  tenosynovitis in an 
immunocompetent patient involving Mycobacterium 
xenopi, and would like to report a patient with arthritis 
of the left shoulder and spondylodiscitis due to 
M . xenopi.
A 56-yr-old w om an to the out-patient
oclinic with a painful left shoulder. This pain started 
months before, and gradually increased. The p;
with a
iY/.i
had been suffering from systemic lupus er 
(SLE) for > 2 0 y r ,  which was 
combination of low-dose corticosteroids 
prine. She had never before experienced painful joints. 
Apart from the painful left shoulder, she had some 
dyspnoea on exertion. Physical exam ination  was 
unremarkable except for a swollen left shoulder 
with a solid, 2.5 cm tum our on top of 
acromioclavicular joint. Movements of the shoulder 
were tender and  m oderately  limited in all directions. 
Laboratory exam inations revealed a slightly elevated 
ESR (28 mm/h); renal and liver function  tests, and  
blood counts were in the normal range, 
yielded 2.5 ml o f  clear synovial fluid, w ithout crystals 
on microscopic exam ination. G ram  and Ziehl-Neelsen 
stains were negative, as were routine bacterial and 
fungal cultures. A spirate  was inoculated onto  Lowen-
ration
stein-Jensen and Middlebrook K7 H10 culture 
medium, and incubated at 30 and 37 C. A Mantoux 
reaction remained negative. A chest X-ray showed no 
abnormalities, an X-ray of the left shoulder revealed
some nation o f  the distal part of the 
clavicle, and an enlarged joint space of the acromio­
clavicular joint. Ultrasound examination showed an 
increased mass of the synovial tissue of the acromio-
clavicular 
the
a n d glenohumeral of
and subacromial bursa. Magnetic 
resonance imaging (MRI) confirmed these findings. A
o fproposed arthroscopy was 
spontaneous reduction of the pain and swelling of the
Two months later, she presented with back pain. The 
VMIth and IXth thoracic vertebrae were painful on 
palpation. The left shoulder was still slightly limited in 
motion. Routine laboratory examinations were normal
for an elevated ESR (31 mm/h). X-ray 
examination of the thoracic spine was suggestive for 
spondylodiscitis of these vertebrae. MRI examination 
showed a decreased T1 and increased T2 signal 
intensity of the VUIth and IXth thoracic vertebrae, and 
the intervertebral disc, compatible with spondylo­
discitis. Histological examination of several biopsies, 
taken from the inflammatory lesion of the VUIth and 
IXth thoracic vertebrae, revealed low-grade chronic 
osteomyelitis, without granulomata. Gram and Ziehl- 
Neelsen stains of the biopsy specimen were negative. At
time, cultures of the synovial fluid o f  the left
21*, U ? months previously.
growth o f  a Mycobacterium species, later identified as 
M. xenopi. Cultures from the biopsy specimen became
A ^  M.
a • 7 incubation.
to isom
•  M .  .
testing showed that M. xenopi was sensitive 
c 1 a r i t h r o m y c i n , e i p r o 11 o x a e i n, 
lampren,
I 1
and
resistant to rilampicm and eth- 
Friple anti-tuberculous therapy, 
of isoniazid, clarithromycin and ciprofloxacin,
months of treatment, the pain in her 
spine and left shoulder abated, and the ESR had fallen 
to 17 mm/h. Anti-tuberculous trea tment was discontin-
t . »mita
lied after 9 months. Since then, with a follow-up o f  30 
months, the patient feels well and no recurrence of the
infection was noted. ultrasound
examination of the left shoulder showed calcifications 
of the tendons of the biceps and supraspinate muscles,
t an MRI of the thoracic vertebrae
destruction of the VUIth vertebra, with normal T1 ,
T2 signal intensities.
As made clear in the article of Coombes el til. [1], 
M . xenopi rarely causes non-pulmonary disease. Only 
a few reports mention musculoskeletal disease due to 
M . xenopi [2], Spinal infections due to M. xenopi have 
been reported before in four patients [3 6], Like our 
patient, two of these patients were suffering from SLE,
low doses of corticosteroids. In our
* nt'f. xenopi was the cause of
;r and the spondylodiscitis. To the 
best o f  our knowledge, this combination of infections
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caused by M. xenopi has not been reported before. It 
illustrates that in patients with rheumatic diseases with 
recent onset inflammation of any part o f  the 
musculoskeletal system, mycobacteria should be 
considered as a possible causative agent, especially 
when immunosuppressive drugs are used.
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Publicity cannot be controlled. Deighton
and Doherty’s suggestions are uninformed, naive and 
impossible to implement. Openness with information 
and honest debate can at least make the processes of 
science accessible to the public.
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it, Bristol Royal Infirmary, Bristol
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Informing the Public About Treatment Advances
Sir— In their viewpoint ar Deighton a n d
Doherty [1] propose guidelines for the publicity o f  
therapeutic research advances. Unfortunately, their 
proposals serve no useful purpose and do not relate in 
any way to the process by which the media report and 
comment upon scientific developments. Your journal 
would do better to have commissioned an article from 
those who have dealt more fully with this area and have 
consulted more widely.
In the case o f  the developments with which I was 
involved [2] and which Deighton and Doherty quote, 
the initial publicity was generated by a national charity 
at the time of the award of the research grant which
made the study was reinforced by the
learned society which decided to issue a press release at 
the time of presentation of the earliest abstract, and
by press coverage related to the annual 
Arthritis Education Week (which was not directly 
related to the report). In practice, however, the Press 
Association and other journalists were continually 
pressing for further information about the study 
from its earliest days. It was seen by scientific reporters 
as an important story, and did, after all, report a new 
and important therapeutic advance which was immedi­
ately available to thousands of people all over 
world.
Reply
The response by D r  Kirwan unfortunately reinforces 
the concerns expressed in our viewpoint article [1]. His 
perspective as the principal investigator, echoed widely 
by the media, was that low-dose corticosteroid ‘is a new 
and important therapeutic advance’. This treatment 
was not new, was not a major advance, did not have 
its potential caveats discussed, and was not placed in 
the context o f  other treatments. Subsequent to its 
publication [2], the study has not been widely perceived 
as the seminal work Dr Kirwan believes it to be [3]. 
Public ‘education’ a t the time of his grant award, when 
the abstract was first presented, and then on the day 
the paper appeared, was hardly likely to encourage 
balanced appraisal of the merits of the work. Because 
corticosteroids were ‘immediately available’, consider­
able re-education o f  disappointed patients was required 
in the wake o f  the publicity. Dr Kirwan does not 
concede this problem and may have missed it whilst 
engaged with the media.
We may be naive and uninformed in many matters,
but between us have and Dr
Kirwan on the A R C  Education Committee, have been 
involved in British Medical Journal policy on national 
media coverage, and have been directly involved in 
newspaper, radio and television ‘news items’. Before 
writing the viewpoint, we canvassed opinion from GPs, 
rheumatologists and  uARC officers, many o f  whom 
shared our concerns. Dr Kirwan accepts the immediacy 
of the press and believes it leads to honest debate. His 
own example, however, does not inspire confidence. 
We do not accept the inevitability of media 
domination, but favour continuing debate on how to 
improve mechanisms that impart accurate information 
with minimal bias and sensationalism.
C. D e ig h to n , M.
r 1 11
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